foxo4-dri senolytic peptide human trials inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Buy FOXO4-DRI 10mg | Third-Party
Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology
Pay in 4 interest-free payments of $5.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14





